Nano-X Imaging (NNOX) Cash & Equivalents (2019 - 2025)

Nano-X Imaging (NNOX) has 7 years of Cash & Equivalents data on file, last reported at $49.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Equivalents rose 25.05% year-over-year to $49.2 million; the trailing twelve-month figure through Dec 2025 stood at $49.2 million (up 25.05% YoY), and the FY2025 full-year result was $39.3 million, down 30.28% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $49.2 million, up from $45.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $219.6 million in Q1 2021 and bottomed at $37.6 million in Q1 2023.
• The 5-year median for Cash & Equivalents is $49.5 million (2025), against an average of $61.3 million.
• The widest annual swing landed in 2022, when Cash & Equivalents tumbled 74.93%; it then surged 64.6% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $66.8 million in 2021, then slumped by 42.4% to $38.5 million in 2022, then soared by 46.57% to $56.4 million in 2023, then plunged by 30.28% to $39.3 million in 2024, then increased by 25.05% to $49.2 million in 2025.
• The last three Cash & Equivalents figures came in at $49.2 million (Q4 2025), $45.2 million (Q3 2025), and $49.9 million (Q2 2025), per Business Quant data.

Peer Comparison